Alzheimer’s disease is the most common form of dementia, which is known for affecting cognitive functions. It starts with memory loss, followed by the incapacity to perform daily activities and in the end, by affecting communicative ability. It usually sets in during old age though there are cases in which people have contracted it in their forties. It is the fourth most common cause of death for adults after cardiovascular disease, cancer and cerebral stroke.
According to World Health Organization, the number of patients with dementia is increasing. It is estimated that by 2030, the number of patients with dementia will double, and by 2050 it will triple. Out of all patients, 71% live in countries with small or average income.
Dr. Reddy’s products for treating Alzheimer’s disease form a part of our ongoing efforts towards developing new drug combinations that enhance the quality of life in patients.
|Memantine Dr. Reddy’s
|Rivastigmine Dr. Reddy’s
|4,6 mg/24 ore; 9,5 mg/24 ore